Planet 13 Holdings (PLNH) Depreciation & Amortization (CF) (2021 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Depreciation & Amortization (CF) of $2.2 million for Q1 2026, down 27.83% year-over-year from $3.1 million in Q1 2025, and down 5.86% quarter-over-quarter from $2.4 million in Q4 2025.
Planet 13 Holdings (PLNH) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Depreciation & Amortization (CF) for 6 consecutive years, with $2.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 27.83% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $10.5 million (down 21.79% YoY), while the FY2025 annual figure was $11.4 million, down 15.02% from the prior year.
- Depreciation & Amortization (CF) fell to $2.2 million in Q1 2026 per PLNH's latest filing, from $2.4 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $3.6 million in Q4 2024 and bottomed at $2.2 million in Q1 2026.
- Historically, Depreciation & Amortization (CF) has averaged $3.0 million across 5 years, with a median of $3.0 million in 2023.
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 173.95% — and 2025, when it sank 34.12%.
- Planet 13 Holdings' Depreciation & Amortization (CF) stood at $3.1 million in 2022, then retreated by 4.5% to $3.0 million in 2023, then grew by 21.03% to $3.6 million in 2024, then tumbled by 34.12% to $2.4 million in 2025, then retreated by 5.86% to $2.2 million in 2026.
- Business Quant data shows PLNH's Depreciation & Amortization (CF) at $2.2 million in Q1 2026, $2.4 million in Q4 2025, and $2.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Planet 13 Holdings | 50.16 Mn | 33.68 Mn | 12.32 Mn | 2.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.19 Mn |
| Jun 30, 2026 | 2.19 Mn |
| Mar 31, 2026 | 2.22 Mn |
| Mar 31, 2026 | 2.22 Mn |
| Dec 31, 2025 | 2.36 Mn |
| Dec 31, 2025 | 2.36 Mn |
| Sep 30, 2025 | 2.75 Mn |
| Sep 30, 2025 | 2.75 Mn |
| Jun 30, 2025 | 3.20 Mn |
| Jun 30, 2025 | 3.20 Mn |
| Mar 31, 2025 | 3.08 Mn |
| Mar 31, 2025 | 3.08 Mn |
| Dec 31, 2024 | 3.59 Mn |
| Dec 31, 2024 | 3.59 Mn |
| Sep 30, 2024 | 3.58 Mn |
| Sep 30, 2024 | 3.58 Mn |
| Jun 30, 2024 | 3.23 Mn |
| Jun 30, 2024 | 3.23 Mn |
| Mar 31, 2024 | 3.02 Mn |
| Mar 31, 2024 | 3.02 Mn |